| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/13/2023 | 689.47% | HC Wainwright & Co. | $45 → $36 | Maintains | Buy |
| 08/10/2023 | 886.84% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 06/08/2023 | 886.84% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 05/17/2023 | 886.84% | HC Wainwright & Co. | → $45 | Reiterates | Buy → Buy |
| 03/29/2023 | 886.84% | HC Wainwright & Co. | $48 → $45 | Maintains | Buy |
| 04/11/2022 | 952.63% | HC Wainwright & Co. | $49 → $48 | Maintains | Buy |
| 01/11/2022 | 886.84% | Jefferies | → $45 | Initiates Coverage On | → Buy |
| 11/24/2021 | 974.56% | HC Wainwright & Co. | $47 → $49 | Maintains | Buy |
| 10/01/2021 | — | Cowen & Co. | Initiates Coverage On | → Outperform | |
| 09/14/2021 | 1018.42% | Ladenburg Thalmann | → $51 | Initiates Coverage On | → Buy |
| 09/08/2021 | 886.84% | Piper Sandler | → $45 | Initiates Coverage On | → Overweight |
| 08/30/2021 | 930.7% | HC Wainwright & Co. | $22 → $47 | Maintains | Buy |
What is the target price for Aadi Bioscience (AADI)?
The latest price target for Aadi Bioscience (NASDAQ: AADI) was reported by HC Wainwright & Co. on November 13, 2023. The analyst firm set a price target for $36.00 expecting AADI to rise to within 12 months (a possible 689.47% upside). 5 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Aadi Bioscience (AADI)?
The latest analyst rating for Aadi Bioscience (NASDAQ: AADI) was provided by HC Wainwright & Co., and Aadi Bioscience maintained their buy rating.
When is the next analyst rating going to be posted or updated for Aadi Bioscience (AADI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Aadi Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Aadi Bioscience was filed on November 13, 2023 so you should expect the next rating to be made available sometime around November 13, 2024.
Is the Analyst Rating Aadi Bioscience (AADI) correct?
While ratings are subjective and will change, the latest Aadi Bioscience (AADI) rating was a maintained with a price target of $45.00 to $36.00. The current price Aadi Bioscience (AADI) is trading at is $4.56, which is out of the analyst's predicted range.